Changes of the width between cuspids and first molars (plaster models) · Children with obstructive sleep apnoea (aged 15 years or younger)
The review found no eligible studies for this question.
1 finding from 1 review
OME resolution at long‐term · Children with otitis media with effusion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms · Children with otitis media with effusion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects [2 weeks to 6 months] · Children with otitis media with effusion
Summary of findings: oral steroids plus antibiotic showed no clear difference in adverse effects [2 weeks to 6 months] compared with control plus antibiotic (low certainty).
1 finding from 1 review
Hearing loss · Children with otitis media with effusion
Summary of findings: oral steroids plus antibiotic showed no clear difference in hearing loss [2 months]1 compared with control plus antibiotic (moderate certainty).
1 finding from 1 review
OME resolution at short‐term · Children with otitis media with effusion
Summary of findings: oral steroids plus antibiotic leads to higher OME resolution at short‐term compared with control plus antibiotic (high certainty).
1 finding from 1 review
OME resolution at intermediate‐term · Children with otitis media with effusion
1 finding from 1 review
Hypoglycaemia · women with type 2 diabetes
It is very uncertain whether infant outcomes: oral anti‐diabetic agent (metformin) changes hypoglycaemia compared with insulin (very low certainty).
1 finding from 1 review
Health status and well‐being – neonatal morbidity and mortality combined · women with type 2 diabetes
1 finding from 1 review
Neurosensory disability · women with type 2 diabetes
1 finding from 1 review
Childhood/adulthood adiposity · women with type 2 diabetes
1 finding from 1 review
Childhood/adulthood diabetes · women with type 2 diabetes
1 finding from 1 review
Large‐for‐gestational age · women with type 2 diabetes
It is very uncertain whether infant outcomes: oral anti‐diabetic agent (metformin) changes large‐for‐gestational age compared with insulin (very low certainty).
1 finding from 1 review
Perinatal mortality · women with type 2 diabetes
1 finding from 1 review
Hypertensive disorders of pregnancy: pre‐eclampsia · women with type 2 diabetes
It is very uncertain whether maternal outcomes: oral anti‐diabetic agent (metformin) changes hypertensive disorders of pregnancy: pre‐eclampsia compared with insulin (very low certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy (pregnancy‐induced hypertension) · women with type 2 diabetes
Maternal outcomes: oral anti‐diabetic agent (metformin) may leads to lower hypertensive disorders of pregnancy: pregnancy‐induced hypertension compared with insulin (low certainty).
1 finding from 1 review
Caesarean section · women with type 2 diabetes
Maternal outcomes: oral anti‐diabetic agent (metformin) may leads to lower caesarean section compared with insulin (low certainty).
1 finding from 1 review
Induction of labour · women with type 2 diabetes
It is very uncertain whether maternal outcomes: oral anti‐diabetic agent (metformin) changes induction of labour compared with insulin (very low certainty).
1 finding from 1 review
Perineal trauma · women with type 2 diabetes
1 finding from 1 review
Postnatal depression · women with type 2 diabetes
1 finding from 1 review